Sonja Alsemgeest Swanson, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mendelian Randomization Analysis | 18 | 2023 | 967 | 5.740 |
Why?
|
| Causality | 12 | 2023 | 1275 | 2.880 |
Why?
|
| Suicide | 9 | 2023 | 1477 | 1.570 |
Why?
|
| Firearms | 6 | 2023 | 598 | 1.450 |
Why?
|
| Data Interpretation, Statistical | 9 | 2020 | 2716 | 1.260 |
Why?
|
| Binge-Eating Disorder | 10 | 2018 | 137 | 1.080 |
Why?
|
| Bulimia Nervosa | 13 | 2018 | 177 | 1.030 |
Why?
|
| Dementia | 4 | 2023 | 2518 | 0.950 |
Why?
|
| Epidemiologic Methods | 2 | 2019 | 1364 | 0.840 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2023 | 2408 | 0.790 |
Why?
|
| Selection Bias | 3 | 2019 | 371 | 0.740 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 9 | 2016 | 1953 | 0.590 |
Why?
|
| Bulimia | 5 | 2016 | 382 | 0.570 |
Why?
|
| Models, Statistical | 7 | 2020 | 5102 | 0.530 |
Why?
|
| Sigmoidoscopy | 1 | 2015 | 156 | 0.520 |
Why?
|
| Epidemiologic Research Design | 2 | 2021 | 367 | 0.500 |
Why?
|
| Antidepressive Agents | 5 | 2016 | 2838 | 0.440 |
Why?
|
| Comparative Effectiveness Research | 2 | 2015 | 681 | 0.440 |
Why?
|
| Genetic Variation | 5 | 2021 | 6544 | 0.420 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.420 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2373 | 0.410 |
Why?
|
| Interview, Psychological | 7 | 2015 | 812 | 0.400 |
Why?
|
| Smoking Cessation | 1 | 2023 | 2071 | 0.390 |
Why?
|
| Humans | 106 | 2023 | 744343 | 0.390 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 320 | 0.390 |
Why?
|
| Body Image | 4 | 2017 | 610 | 0.380 |
Why?
|
| Self-Injurious Behavior | 6 | 2016 | 465 | 0.370 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2016 | 6038 | 0.360 |
Why?
|
| Research Report | 1 | 2013 | 355 | 0.350 |
Why?
|
| Pregnancy Complications | 3 | 2022 | 2861 | 0.330 |
Why?
|
| Emigration and Immigration | 1 | 2011 | 404 | 0.320 |
Why?
|
| Anorexia Nervosa | 9 | 2018 | 1286 | 0.320 |
Why?
|
| Body Weight | 8 | 2017 | 4669 | 0.320 |
Why?
|
| Anxiety Disorders | 7 | 2016 | 2690 | 0.310 |
Why?
|
| Public Health | 1 | 2021 | 2603 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3255 | 0.300 |
Why?
|
| Monte Carlo Method | 2 | 2016 | 1254 | 0.300 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 3658 | 0.300 |
Why?
|
| Gastrointestinal Diseases | 2 | 2013 | 1170 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 9959 | 0.290 |
Why?
|
| Prevalence | 12 | 2020 | 15226 | 0.290 |
Why?
|
| Epidemiology | 2 | 2021 | 287 | 0.270 |
Why?
|
| Female | 67 | 2023 | 380194 | 0.270 |
Why?
|
| Substance-Related Disorders | 9 | 2016 | 4258 | 0.270 |
Why?
|
| Depression | 6 | 2016 | 7766 | 0.270 |
Why?
|
| Suicide, Attempted | 4 | 2015 | 1221 | 0.260 |
Why?
|
| Blood Pressure | 1 | 2020 | 8554 | 0.250 |
Why?
|
| Mood Disorders | 3 | 2012 | 1106 | 0.250 |
Why?
|
| Adolescent | 35 | 2018 | 85781 | 0.250 |
Why?
|
| Mental Disorders | 7 | 2015 | 6600 | 0.250 |
Why?
|
| Longitudinal Studies | 13 | 2023 | 13989 | 0.250 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1405 | 0.250 |
Why?
|
| Pandemics | 2 | 2022 | 8388 | 0.250 |
Why?
|
| Research Design | 4 | 2022 | 5987 | 0.240 |
Why?
|
| Self Report | 2 | 2017 | 3558 | 0.230 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6487 | 0.220 |
Why?
|
| Hyperphagia | 2 | 2014 | 136 | 0.220 |
Why?
|
| Cohort Studies | 16 | 2023 | 40561 | 0.220 |
Why?
|
| Sex | 1 | 2022 | 57 | 0.220 |
Why?
|
| Hypertension | 2 | 2020 | 8480 | 0.220 |
Why?
|
| Stroke | 3 | 2020 | 9981 | 0.220 |
Why?
|
| Male | 56 | 2022 | 350118 | 0.210 |
Why?
|
| Pregnancy | 9 | 2023 | 29144 | 0.210 |
Why?
|
| Medicaid | 1 | 2015 | 2736 | 0.200 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3086 | 0.200 |
Why?
|
| Communication | 1 | 2015 | 3749 | 0.200 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2015 | 503 | 0.200 |
Why?
|
| Parents | 2 | 2016 | 3407 | 0.190 |
Why?
|
| Pleural Effusion, Malignant | 2 | 1998 | 101 | 0.190 |
Why?
|
| Ownership | 2 | 2020 | 332 | 0.180 |
Why?
|
| Registries | 1 | 2016 | 8089 | 0.180 |
Why?
|
| Probability | 2 | 2022 | 2505 | 0.180 |
Why?
|
| Comorbidity | 9 | 2017 | 10388 | 0.170 |
Why?
|
| Policy | 1 | 2023 | 508 | 0.170 |
Why?
|
| Cholesterol, HDL | 2 | 2023 | 1814 | 0.170 |
Why?
|
| Suicidal Ideation | 3 | 2014 | 1248 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2021 | 229 | 0.170 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 57776 | 0.160 |
Why?
|
| Venules | 1 | 2018 | 165 | 0.160 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 711 | 0.160 |
Why?
|
| Goals | 1 | 2023 | 706 | 0.160 |
Why?
|
| Adolescent Behavior | 3 | 2016 | 1151 | 0.150 |
Why?
|
| Ascitic Fluid | 1 | 1997 | 192 | 0.150 |
Why?
|
| Child | 20 | 2023 | 77709 | 0.150 |
Why?
|
| Risk Factors | 14 | 2023 | 72290 | 0.150 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 426 | 0.150 |
Why?
|
| Databases as Topic | 1 | 2019 | 475 | 0.150 |
Why?
|
| Young Adult | 21 | 2020 | 56430 | 0.140 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 12261 | 0.140 |
Why?
|
| Middle Aged | 27 | 2021 | 213383 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 6773 | 0.130 |
Why?
|
| Reference Standards | 1 | 2019 | 1025 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2011 | 3309 | 0.130 |
Why?
|
| Pericardial Effusion | 1 | 1997 | 247 | 0.130 |
Why?
|
| Surrogate Mothers | 1 | 2014 | 17 | 0.130 |
Why?
|
| Paroxetine | 1 | 2015 | 182 | 0.130 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 304 | 0.130 |
Why?
|
| Pregnancy Outcome | 3 | 2022 | 2795 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 1997 | 338 | 0.120 |
Why?
|
| Norway | 1 | 2015 | 448 | 0.120 |
Why?
|
| Body Size | 1 | 2017 | 461 | 0.120 |
Why?
|
| Adult | 33 | 2022 | 214055 | 0.120 |
Why?
|
| Age Factors | 9 | 2019 | 18370 | 0.120 |
Why?
|
| Checklist | 1 | 2021 | 833 | 0.120 |
Why?
|
| Smoking | 2 | 2023 | 8987 | 0.120 |
Why?
|
| Cholesterol | 1 | 2023 | 2917 | 0.120 |
Why?
|
| Health Surveys | 6 | 2014 | 4037 | 0.120 |
Why?
|
| United States | 17 | 2018 | 69872 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 1125 | 0.120 |
Why?
|
| Mastication | 1 | 2013 | 53 | 0.120 |
Why?
|
| Pregnancy Rate | 2 | 2014 | 643 | 0.110 |
Why?
|
| Drug Labeling | 1 | 2015 | 233 | 0.110 |
Why?
|
| Travel | 1 | 2019 | 788 | 0.110 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 1411 | 0.110 |
Why?
|
| Data Collection | 1 | 2022 | 3341 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 242 | 0.110 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2014 | 189 | 0.110 |
Why?
|
| California | 3 | 2022 | 1402 | 0.110 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2013 | 160 | 0.100 |
Why?
|
| Feeding Behavior | 3 | 2013 | 3188 | 0.100 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 230 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11727 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1432 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2017 | 25043 | 0.100 |
Why?
|
| Aged | 15 | 2020 | 163280 | 0.100 |
Why?
|
| Propensity Score | 2 | 2015 | 1781 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2018 | 23338 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2023 | 3528 | 0.090 |
Why?
|
| Neoplasms, Second Primary | 1 | 1998 | 1061 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 1998 | 6364 | 0.090 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2014 | 482 | 0.090 |
Why?
|
| Mental Health Services | 2 | 2012 | 1643 | 0.090 |
Why?
|
| Time Factors | 3 | 2019 | 40075 | 0.090 |
Why?
|
| Body Mass Index | 5 | 2016 | 12720 | 0.090 |
Why?
|
| Premature Birth | 1 | 2022 | 1721 | 0.090 |
Why?
|
| Epidemiologic Studies | 1 | 2013 | 676 | 0.090 |
Why?
|
| Obesity | 4 | 2019 | 12745 | 0.090 |
Why?
|
| Infertility, Male | 1 | 2013 | 409 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1462 | 0.090 |
Why?
|
| Mexico | 1 | 2011 | 690 | 0.090 |
Why?
|
| Mental Competency | 1 | 2010 | 176 | 0.090 |
Why?
|
| Drug Prescriptions | 2 | 2016 | 1637 | 0.090 |
Why?
|
| Anorexia | 1 | 2010 | 161 | 0.090 |
Why?
|
| Granulosa Cell Tumor | 1 | 1990 | 71 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2013 | 625 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2282 | 0.080 |
Why?
|
| Depressive Disorder | 4 | 2015 | 3748 | 0.080 |
Why?
|
| Netherlands | 3 | 2019 | 2170 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3508 | 0.080 |
Why?
|
| Sex Factors | 4 | 2019 | 10397 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39050 | 0.080 |
Why?
|
| Eating | 2 | 2013 | 1536 | 0.080 |
Why?
|
| Canada | 1 | 2013 | 2065 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 1997 | 1583 | 0.080 |
Why?
|
| Botswana | 2 | 2022 | 1040 | 0.080 |
Why?
|
| Molecular Epidemiology | 1 | 2010 | 468 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2020 | 2788 | 0.080 |
Why?
|
| Patient Selection | 2 | 2019 | 4215 | 0.080 |
Why?
|
| Child Development | 1 | 2019 | 2223 | 0.070 |
Why?
|
| Age of Onset | 2 | 2011 | 3271 | 0.070 |
Why?
|
| Anthropometry | 1 | 2012 | 1350 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 651 | 0.070 |
Why?
|
| Long-Term Care | 1 | 2010 | 607 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2021 | 8324 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 20947 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2019 | 53288 | 0.070 |
Why?
|
| Research Personnel | 2 | 2023 | 573 | 0.070 |
Why?
|
| Educational Status | 1 | 2014 | 2540 | 0.070 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 482 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63114 | 0.060 |
Why?
|
| Cause of Death | 4 | 2020 | 3584 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12245 | 0.060 |
Why?
|
| Child Abuse | 1 | 2013 | 1030 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 14722 | 0.060 |
Why?
|
| Body Composition | 1 | 2014 | 2401 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2016 | 2063 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7913 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3265 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 722 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15076 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15519 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2018 | 9146 | 0.060 |
Why?
|
| Severity of Illness Index | 7 | 2016 | 15540 | 0.060 |
Why?
|
| Headache | 1 | 2011 | 1226 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2015 | 1947 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1997 | 4034 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13284 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 3057 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 2418 | 0.050 |
Why?
|
| Interleukin-10 Receptor beta Subunit | 1 | 2021 | 15 | 0.050 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2021 | 107 | 0.050 |
Why?
|
| Weight Gain | 1 | 2011 | 2292 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2010 | 1102 | 0.050 |
Why?
|
| Interviews as Topic | 3 | 2013 | 2539 | 0.050 |
Why?
|
| Micronutrients | 1 | 2022 | 375 | 0.040 |
Why?
|
| Researcher-Subject Relations | 1 | 2018 | 16 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4644 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2022 | 25625 | 0.040 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 1997 | 44 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2019 | 505 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2010 | 1620 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 29063 | 0.040 |
Why?
|
| Risk | 3 | 2015 | 9687 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 956 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
| Overweight | 3 | 2013 | 2371 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 346 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5751 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2019 | 407 | 0.030 |
Why?
|
| Population | 1 | 2016 | 142 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2013 | 4266 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 16718 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2019 | 41006 | 0.030 |
Why?
|
| DNA | 1 | 1990 | 7301 | 0.030 |
Why?
|
| Folic Acid | 1 | 2022 | 1300 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
| Contracts | 1 | 2014 | 60 | 0.030 |
Why?
|
| Age Distribution | 2 | 2011 | 2902 | 0.030 |
Why?
|
| Sertraline | 1 | 2015 | 206 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 29786 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2016 | 77449 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 13102 | 0.030 |
Why?
|
| Ontario | 1 | 2014 | 383 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 824 | 0.030 |
Why?
|
| Phenotype | 1 | 2011 | 16365 | 0.030 |
Why?
|
| Intelligence | 1 | 2019 | 920 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Birth Rate | 1 | 2014 | 170 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1099 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2019 | 0.030 |
Why?
|
| New Zealand | 1 | 2013 | 355 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 4838 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21746 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2014 | 571 | 0.030 |
Why?
|
| Citalopram | 1 | 2015 | 403 | 0.030 |
Why?
|
| Students | 1 | 2022 | 1654 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 392 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 634 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2356 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 1997 | 607 | 0.030 |
Why?
|
| Fluoxetine | 1 | 2015 | 749 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 21683 | 0.030 |
Why?
|
| Health Services Research | 1 | 2019 | 1836 | 0.030 |
Why?
|
| Telemedicine | 1 | 2009 | 2872 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 26385 | 0.020 |
Why?
|
| Psychopathology | 1 | 2014 | 409 | 0.020 |
Why?
|
| Patient Preference | 1 | 2018 | 890 | 0.020 |
Why?
|
| Minnesota | 1 | 2011 | 344 | 0.020 |
Why?
|
| Mesothelioma | 1 | 1997 | 818 | 0.020 |
Why?
|
| Migraine without Aura | 1 | 2011 | 83 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 19905 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 1997 | 1094 | 0.020 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 234 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13408 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2022 | 3297 | 0.020 |
Why?
|
| Indoles | 1 | 1997 | 1839 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.020 |
Why?
|
| Parenting | 1 | 2014 | 679 | 0.020 |
Why?
|
| Migraine with Aura | 1 | 2011 | 203 | 0.020 |
Why?
|
| Attention | 1 | 2019 | 2400 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3019 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 647 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 636 | 0.020 |
Why?
|
| Psychology | 1 | 2010 | 356 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 7279 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1584 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2010 | 631 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 1523 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 7785 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1990 | 530 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 2297 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 969 | 0.020 |
Why?
|
| Motivation | 1 | 2016 | 1971 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1997 | 3690 | 0.020 |
Why?
|
| Body Height | 1 | 2012 | 1577 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2278 | 0.020 |
Why?
|
| Microscopy | 1 | 1990 | 903 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3843 | 0.020 |
Why?
|
| Survival Rate | 1 | 1998 | 12788 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15165 | 0.010 |
Why?
|
| Psychometrics | 1 | 2013 | 3002 | 0.010 |
Why?
|
| Infant | 2 | 2019 | 35136 | 0.010 |
Why?
|
| Cell Division | 1 | 1990 | 4568 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
| Alcoholism | 1 | 2010 | 1906 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5952 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2009 | 1859 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1990 | 5974 | 0.010 |
Why?
|
| Mortality | 1 | 2009 | 2864 | 0.010 |
Why?
|
| Sleep | 1 | 2014 | 4623 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1997 | 374 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5391 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2009 | 3209 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 3158 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12959 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 3129 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1997 | 9239 | 0.000 |
Why?
|
| Mice | 1 | 1997 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 1997 | 168757 | 0.000 |
Why?
|